The Enterprise Value as of June 2026 (TTM) for Appili Therapeutics Inc. (APLIF) is 14.17M

According to Appili Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.17M. This represents a change of -1.41% compared to the average of 14.38M of the last 4 quarters.

Appili Therapeutics Inc. (APLIF) Historical Enterprise Value (quarterly & annually)

How has APLIF Enterprise Value performed in the past?

The mean historical Enterprise Value of Appili Therapeutics Inc. over the last ten years is 19.85M. The current 14.17M Enterprise Value has changed 7.04% with respect to the historical average. Over the past ten years (40 quarters), APLIF's Enterprise Value was at its highest in in the September 2020 quarter at 71.33M. The Enterprise Value was at its lowest in in the December 2017 quarter at 0.

Appili Therapeutics Inc. (APLIF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Appili Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Appili Therapeutics Inc. (APLIF) Average Enterprise Value

How has APLIF Enterprise Value performed in the past?

The current Enterprise Value of Appili Therapeutics Inc. (APLIF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Appili Therapeutics Inc. (APLIF) Enterprise Value vs. Peers

How is APLIF’s Enterprise Value compared to its peers?

Appili Therapeutics Inc.’s Enterprise Value is greater than Algernon Pharmaceuticals Inc. (-52507.00), greater than ReNeuron Group plc (-5685215.39), less than Ayala Pharmaceuticals, Inc. (29.14M), greater than Universal Ibogaine Inc. (4.01M), greater than Restart Life Sciences Corp. (2.50M), greater than Regen BioPharma, Inc. (974.11K), greater than SB Technology Holdings, Inc. (421.91K), greater than America Great Health (7.12M), greater than Imagion Biosystems Limited (4.25M), greater than Health Sciences Group, Inc. (2.19M),

Build a custom stock screener for Appili Therapeutics Inc. (APLIF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Appili Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Appili Therapeutics Inc. (APLIF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Appili Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.